NPI: 1912967126 · BALTIMORE, MD 21201 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 33,240 | $113K |
| 2019 | 29,285 | $180K |
| 2020 | 18,862 | $244K |
| 2021 | 19,823 | $282K |
| 2022 | 16,195 | $273K |
| 2023 | 12,701 | $312K |
| 2024 | 5,477 | $202K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,698 | 2,991 | $1.02M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 50,907 | 3,144 | $342K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 387 | 228 | $87K |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,220 | 2,171 | $67K |
| J1756 | Injection, iron sucrose, 1 mg | 8,632 | 2,365 | $61K |
| 83970 | 2,938 | 2,606 | $20K | |
| A4657 | Syringe, with or without needle, each | 7,084 | 3,498 | $6K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 744 | 378 | $5K |
| 83550 | 2,207 | 1,910 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,112 | 799 | $0.00 |
| 82728 | 2,071 | 1,832 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 245 | 223 | $0.00 |
| 90674 | 67 | 54 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 60 | 54 | $0.00 |
| 85041 | 2,850 | 2,590 | $0.00 | |
| 85048 | 2,821 | 2,563 | $0.00 | |
| 83540 | 2,330 | 2,024 | $0.00 | |
| 82108 | 196 | 157 | $0.00 | |
| 90662 | 14 | 14 | $0.00 |